NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 47 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | -100.0% | 0.00% | – |
| Q4 2018 | $0 | – | 1,000 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 1,000 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 1,000 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 1,000 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 1,000 | -50.0% | 0.00% | – |
| Q3 2017 | $1,000 | -66.7% | 2,000 | -60.0% | 0.00% | – |
| Q2 2017 | $3,000 | 0.0% | 5,000 | 0.0% | 0.00% | – |
| Q1 2017 | $3,000 | +200.0% | 5,000 | +150.0% | 0.00% | – |
| Q4 2016 | $1,000 | -50.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | +100.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | -66.7% | 2,000 | 0.0% | 0.00% | – |
| Q4 2015 | $3,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |